Wednesday, September 7, 2016

Bortezomib

bortezomib be the blue ribbon healthy proteasome inhibitor just before stay weathered now human. it be standard now the u. s. pro relapse manifold myeloma then sheet room lymphoma.? 


pharmacodynamics

bortezomib be a reversible inhibitor of the chymotrypsin-like hobby of the 26- s proteasome. it proteolysis affect manifold chief pro habitual homeostatic function in the room, top just before room casualty.



pharmacokinetics


classification: protein strap: >80%.


metabolism: for all practical purposes metabolised passing through the cytochrome p450 isoenzymes c y p3 a4, c y p2 c19 then c y p1 a2.




bortezomib indication / bortezomib uses

now?  manifold myeloma.



bortezomib bad reaction / bortezomib face effects


asthenic environment; pyrexia; g i trouble, anorexia; drying out; marginal neuropathy; thrombocytopenia, neutropenia, anaemia; hypotension; cardiac disorder; fillet then bulk injure; cough, dyspnoea; brash, oedema; reaction reaction; unpleasant otherwise not easy urination.


potentially critical: pneumonia, pyrexia, diarrhoea, sickness, drying out then queasiness.




precautions

message not available



precise precautions

hepatic otherwise renal decrease; curriculum vitae of syncope, orthostatic hypotension; drying out. proficiency just before power otherwise manage cogs. praepostor pro symptom of marginal neuropathy. praepostor very much the blood glucose now patients getting viva voce antidiabetic agent.



new stimulant interactions

concomitant abuse of amiodarone, antivirals, isoniazid, nitrofurantoin, statins intensify the gamble a accidentally of marginal neuropathy. concomitant abuse of antihypertensives increase the gamble a accidentally of hypotension.



new interactions

message not available



dosage


intravenous


manifold myeloma


grown-up: patients symptom otherwise in addition to upgrade 1 marginal neuropathy symptom: 1.3 mg/m2 in the role of i against bolus across 3-5 flash happening years 1, 4, 8 then 11 of a 21-day run, with a 10-day calm era(years 12-21). by the side of 72 hr be supposed to transpire stuck between successive.


precise populations: genesis of some upgrade 3 non-haematological otherwise upgrade 4 haematological toxicities neuropathy: retain treatment in anticipation of toxicities symptom resolve, next reinitiate by the side of 25% abridged dispense. upgrade 1 in addition to injure otherwise upgrade 2 marginal neuropathy symptom: 1 mg/m2 2x wkly pro 2 wk(years 1, 4, 8, 11), next a 10-day calm era(years 12-21). by the side of 72 hrs transpire stuck between successive dispense. upgrade 2 in addition to injure otherwise upgrade 3 marginal neuropathy symptom: retain treatment in anticipation of toxicity, next ease up on dispense just before 0.7 mg/m2. upgrade 4 marginal neuropathy symptom: withdraw.


overdosage: symptom count hypotension then thrombocytopenia. praepostor reviving then organization impound sustaining trouble oneself.




food( before/after)

message not available



bortezomib then pregnancy

sphere mains: at hand be outright certification of individual foetal lay bare, the remuneration starting abuse now productive women stay passable even with the lay bare(e.g., the stimulant be required now a life-threatening case otherwise pro a deep disability pro which safer drugs cannot stay familiar otherwise unproficient).



bortezomib then lactation

contraindicated now lactation



bortezomib then children

message not available



bortezomib then geriatic

message not available



bortezomib then new contraindications

reaction. progeny. pregnancy then lactation


storage

message not available


lab interference

message not available

No comments:

Post a Comment